🔎 Trials Near Me

Home › Burkitt Lymphoma › Indiana › Indianapolis

Burkitt Lymphoma clinical trials in Indianapolis, IN

5 studies for Burkitt Lymphoma are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

RecruitingPhase 2
  • Riley Hospital for Children, Indianapolis
Ages 1 to 30 · All sexes · Updated Sep 1, 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RecruitingPhase 3
  • Riley Hospital for Children, Indianapolis
  • Ascension Saint Vincent Indianapolis Hospital, Indianapolis
365 Days – 25 Years · All sexes · Updated Aug 25, 2026 · NCT03959085

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

RecruitingPhase 2
  • Riley Hospital for Children - Indiana University, Indianapolis
Ages 1 to 25 · All sexes · Updated May 4, 2025 · NCT03509961

Burkitt Lymphoma trials in other cities

Other studies in Indianapolis

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.